HOOKIPA Pharma (NASDAQ:HOOK) just reported results for the first quarter of 2024.
- HOOKIPA Pharma reported earnings per share of 11 cents. This was above the analyst estimate for EPS of -10 cents.
- The company reported revenue of $36.60 million.
- This was 1,207.11% better than the analyst estimate for revenue of $2.80 million.